| Literature DB >> 32154338 |
Anjum Mobeen Syeda1, K Riazunnisa1.
Abstract
The article reports data on chemical profiling by gas chromatography-mass spectrometry (GC-MS) of aqueous and methanolic leaf extracts of Madagascar periwinkle (Catharanthus roseus) and drumstick tree (Moringa oleifera) and on their antioxidant and antibacterial effects against three clinical human pathogens. In total 105 compounds were tentatively identified; in which 65 in Catharanthus roseus and 40 in Moringa oleifera compounds. A large number of peaks with good area percentage was found in methanolic extract of Catharanthus roseus with core chemical constituents such as trans-squalene, n-hexadecanoic acid, Eicosyl acetate, stearin, 1H-Benz(G)indole-3-carboxylic acid. The corresponding constituents from Moringa oleifera include 9-Octadecenoic acid (z)-, Heptadecanoic acid and phytol acetate. The highest scavenging activity (87.7% at 200 μg/mL) was shown by DPPH aqueous leaf extract of C. roseus. Moreover, the methanolic scavenging of both plant extracts was in the order of FRAP>DPPH>NO> H2O2 with lowest antioxidant activity (51.4% at 200 μg/mL) exposed by Catharanthus roseus in comparison of all cases. Good antibacterial action was examined against three different organisms (E.coli, B. subtilis and S. aureus) of aqueous infusion of Catharanthus roseus.Entities:
Keywords: Anti-oxidant; Antibacterial; Catharanthus roseus; GC-MS; Moringa oleifera
Year: 2020 PMID: 32154338 PMCID: PMC7058890 DOI: 10.1016/j.dib.2020.105258
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1GC-MS Chromatogram of methanolic Catharanthus roseus leaf extract.
Fig. 2GC-MS Chromatogram of aqueous Catharanthus roseus leaf extract.
Fig. 3GC-MS Chromatogram of methanolic Moringa oleifera leaf extract.
Fig. 4GC-MS Chromatogram of aqueous Moringa oleifera leaf extract.
Phytochemicals tentatively identified based on retention time (RT) matching in the methanolic (Left) and aqueous (Right) extracts of Catharanthus roseus leaf extract by GC-MS.
| Sl. No | RT (min.) | NIST DATABASE/Wiley 2007/FAME ID/ | RT (min.) | NIST DATABASE/Wiley 2007/FAME ID/ |
|---|---|---|---|---|
| 1. | 3.34 | 2-Hydroxy-2-methyl-4-pentanone (diacetone) | 6.46 | R (-)-2-Amino-1-butanol |
| 2. | 8.23 | 4-Penten-2-Ol, 3-methyl- | 6.55 | Phenethylamine, alpha-ethyl- |
| 3. | 14.17 | Quinoline, 1,2-dihydro-2,2,4-trimethyl- | 6.77 | 1-Butanol, 2-amino- |
| 4. | 15.85 | Hexathiane | 7.67 | 2,4(1H,3H)-Pyrimidinedione |
| 5. | 17.75 | Pentadecane | 8.23 | Naphthalene |
| 6. | 19.20 | 2(3H)-Benzothiazolone | 8.42 | 2,2,5,5-Tetramethylhex-3-ene, 3,4-dideutero |
| 7. | 19.94 | Octadecane | 8.67 | 4-Pyrimidinamine, 2,6-dimethyl |
| 8. | 21.16 | Tetradecanoic Acid | 15.09 | Phenol, 2,4-Bis(1,1-dimethylethyl |
| 9. | 22.07 | Tetracosane | 18.20 | Cyclooctasiloxane, hexadecamethyl |
| 10. | 23.22 | Octadecanoic Acid | 20.29 | 1,3-Diphenyl-1,3,5,5-tetramethyl- |
| 11. | 23.63 | 3-(2-Chloroethyl)-1,3-benzothiazol-2(3H)-one | 20.72 | 1,1,3,3,5,5,7,7,9,9,11,11,13,13-Tetradeca |
| 12. | 24.10 | Tetracosane | 21.68 | Phosphine Oxide, bis(Pentamethylphenyl)- |
| 13. | 24.75 | 2-(1,3-Benzothiazol-2-ylsulfanyl)ethanol | 22.14 | Hexadecanoic Acid, methyl ester |
| 14. | 25.25 | n-Hexadecanoic acid | 22.64 | n-Hexadecanoic Acid |
| 15. | 26.06 | Tetracosane | 24.15 | 9-Octadecenoic acid, Methyl ester, (E)- |
| 16. | 26.78 | Dodecane, 1,1′-oxybis- | 24.27 | Cyclododecasiloxane, tetracosamethyl |
| 17. | 27.05 | Octathiocane | 24.39 | Hexacosanoic acid, Methyl Ester |
| 18 | 27.93 | Tetracosane | 24.61 | 1,5,9,9-Tetramethyl-2-oxatricyclo [6.4.0.0 (4,8) |
| 19. | 28.68 | Urea | 24.98 | 2-Furanpentanoic acid, tetrahydro-5-nonyl-, methyl |
| 20. | 29.72 | Spiro [Cyclopentane-1,2′ (1′h)-quinoxaline], 3′-(4-morpholinyl)-6′,8′-dinitro- | 25.13 | (2-Methyl-1-phenyl-2-propenyl)Be |
| 21. | 29.63 | Eicosyl Acetate | 25.74 | Cyclononasiloxane, Octadecamethyl- |
| 22. | 31.44 | Tetracosane | 27.42 | 1H-Purin-6-Amine, [(2-fluorophenyl |
| 23. | 32.55 | Stannane, Tributyl (2,5-dimethyl-1-phenyl-4-hexenyl)-, (R∗,R∗)-(.+-.)- | 29.61 | Heptasiloxane, Hexadecamethyl- |
| 24. | 32.74 | Methyl 6,7-dideoxy-6-C-methyl-2,3-di-o-methyl-.alpha.-D-gluco-oct-6-eno-1,5-pyranosid)Urono-8,4-lactone | 30.01 | 1,2-Benzenedicarboxylic acid |
| 25. | 33.21 | Tricosyl acetate | 32.52 | Cyclononasiloxane, octadecamethyl- |
| 26. | 34.78 | Hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester | ||
| 27. | 34.91 | 1,4-Cyclooctanedione | ||
| 28. | 35.42 | 1,2-Benzenedicarboxylic acid | ||
| 29. | 35.11 | Pyrrolo [3,4-C]pyrrole-1-carboxylic Acid, 3-cyclopropyloctahydro-4,6-dioxo-1,5-diphenyl-, methyl ester | ||
| 30. | 36.93 | 4,4′((phenylene)diisopropylidene)diphenol | ||
| 31. | 37.31 | 1H-indole-3-ethanamine | ||
| 32. | 37.90 | Octadecanoic acid, 2,3-dihydroxypropyl ester | ||
| 33. | 38.40 | Heptacyclo [6.6.0.0(2,6).0(3,13).0(4,11).0(5,9).0(10,14)]Tetradecanone | ||
| 34. | 39.28 | 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-Hexamethyl- | ||
| 35. | 41.09 | 1H-Benz [G]indole-3-carboxylic acid, 1-(2,2-dimethoxyethyl)-5-methoxy-2-methyl-, ethyl Ester | ||
| 36. | 43.30 | Cholest-5-en-3-ol (3.Beta.)- | ||
| 37. | 43.89 | 6-Methoxy-2,8-dimethyl-(4′,8′-dimethyl-3′,7′-nonadienyl)-3,4-dihydro-2H-1-Benzopyran | ||
| 38. | 45.74 | Beta.-Sitosterol | ||
| 39. | 45.93 | Ethanone, 1,1′-[3,3′-biisoxazole]-5,5′-diylbis- | ||
| 40. | 46.92 | 3-Butoxy-1,1,1,5,5,5-hexamethyl-3-(Trimethylsiloxy)trisiloxane |
Phytochemicals tentatively identified based on retention time (RT) matching in the methanolic (Left) and aqueous (Right) extracts of Moringa oleifera leaf extract by GC-MS.
| Sl. No | RT (min.) | NIST DATABASE/Wiley 2007/FAME ID/ | RT (min.) | NIST DATABASE/Wiley 2007/FAME ID/ |
|---|---|---|---|---|
| 1. | 8.718 | 1,1-Diethoxy-2-ethylhexane | 17.640 | Benzene, 1,1′-(1,2-cyclobutanediyl |
| 2. | 9.878 | Azulene | 18.252 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol |
| 3. | 13.948 | 2,6-Di-butyl-2,5-cyclohexadiene-1 | 18.736 | pentadecanal- |
| 4. | 17.719 | 9-Octadecenoic acid, ethyl ester | 19.645 | 9-Octadecenoic acid (z)- |
| 5. | 17.896 | 2(4H)-Benzofuranone, 5,6,7,7a tetrahydro | 19.742 | 1,2-Benzenedicarboxylic acid, diheptyl ester |
| 6. | 18.249 | 2,6,10-Trimethyl,14-ethylene-14-pe | 19.925 | 2,5-Pyrrolidinedione, 1-hydroxy- |
| 7. | 18.343 | 2-Pentadecanone, 6,10,14-trimethyl- | 20.085 | Cyclopropanetetradecanoic acid, 2-octyl-, methyl |
| 8. | 18.519 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 20.857 | Phosphonic acid, dioctadecyl ester |
| 9. | 18.736 | Phthalic acid, isobutyl undec-2-en-1-yl ester | 21.842 | Dimethylaminato [4-methyl-2-(e) |
| 10. | 19.587 | l-(+)-Ascorbicacid2,6-dihexadecanoate | 22.122 | Tetradecanamide |
| 11. | 19.750 | Dibutyl phthalate | 24.740 | Heptadecanoic acid, ethyl ester |
| 12. | 19.882 | Hexadecanoic acid, ethyl ester | 25.224 | Hexanedioic acid, mono (2-ethylhexyl)ester |
| 13. | 20.846 | Behenic alcohol | 25.544 | Tetracosyl acetate |
| 14. | 21.197 | 2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, | 26.651 | borneol, Pentamethyldisilanyl ether |
| 15. | 21.550 | 9,12-Octadecadienoic acid (z,z)- | 26.941 | 7-Propyl-1,3,5-cycloheptatriene |
| 16. | 21.735 | (r)-(-)-14-Methyl-8-hexadecyn-1-ol | 27.325 | Octane, 1,1′-oxybis- |
| 17. | 21.827 | 9,12,15-Octadecatrienoic acid, (z,z,z)- | 28.782 | Bis(2-ethylhexyl) phthalate |
| 18. | 22.031 | Heptadecanoic acid, ethyl ester | 29.462 | (2,3-Diphenylcyclopropyl)methyl phenyl sulfoxide, |
| 19. | 22.375 | Phytol, acetate | 29.800 | 1,2-Diphenyl-1-isocyanoethane |
| 20. | 28.779 | Bis(2-ethylhexyl) phthalate | 30.285 | 7-(Isobut-1-yl)cyclohepta-1,3,5-tr |
Fig. 5In-vitro antioxidant activity of aqueous and methanolic leaf extracts of Catharanthus roseus. (A) DPPH scavenging activity (B) H2O2 scavenging activity (C) Nitric oxide scavenging activity (D) FRAP assay. Values are expressed as Mean ± SEM (n = 3). One-way ANOVA followed by Dunnett's test was employed to compare each concentration with positive control. ∗Statistical significance at p < 0.05; ∗∗ statistical significance at p < 0.01. AsA-Ascorbic acid (Positive control); AQ - Aqueous; ME-MeOH.
Fig. 6In-vitro antioxidant activity of aqueous and methanolic leaf extracts of Moringa oleifera. (A) DPPH scavenging activity (B) H2O2 scavenging activity (C) Nitric oxide scavenging activity (D) FRAP assay. Values are expressed as Mean ± SEM (n = 3). One-way ANOVA followed by Dunnett's test was employed to compare each concentration with positive control. ∗Statistical significance at p < 0.05; ∗∗ statistical significance at p < 0.01. AsA-Ascorbic acid (Positive control); AQ-Aqueous; ME-MeOH.
Antimicrobial activity of aqueous and methanolic leaf extracts of Catharanthus roseus and Moringa oleifera against selected bacterial strains.
| Leaf Extracts (50 μg/mL) | Zone of inhibition (mm) | ||
|---|---|---|---|
| Aqueous | 22 ± 0.33 | 23 ± 0.18∗∗ | 25 ± 0.25 |
| Methanolic | 23 ± 0.23 | 23 ± 0.44∗∗ | 20 ± 0.41 |
| Aqueous | 23 ± 0.23∗ | 20 ± 0.25 | 18 ± 0.41 |
| Methanolic | 23 ± 0.65∗ | 24 ± 0.44 | 16 ± 0.23 |
| Tetracycline (1 μg/mL) | 29 ± 0.25 | 36 ± 0.33 | 28 ± 0.46 |
∗Statistical significance at p < 0.05; ∗∗ statistical significance at p < 0.01.
Specifications Table
| Subject | Biology |
| Specific subject area | Medicinal plants and pharmacology |
| Type of data | Chromatogram figures, Tables, Figures, Text files |
| How data were acquired | Crude aqueous and methanolic leaf extracts of |
| Data format | Raw, analyzed and expressed as mean ± SEM, One-way ANOVA analysis of variance. |
| Experimental factors | Aqueous and methanolic extracts of |
| Experimental features | Extraction and isolation of both plant crude extracts (Soxhlet, column chromatography, GC-MS analysis); |
| Data source location | The fresh leaves of the two species of |
| Data accessibility | Provided data in this article |
| Related research article | Mehdi Soltani Howyzeh, Seyed Ahmad Sadat Noori, Vahid Shariati J (2018).Essential oil profiling of Ajowan ( |
Madagascar periwinkle ( Although quite a body of literature is available on Madagascar periwinkle and drumstick tree, the tentatively identified natural compounds with therapeutic potential may be exploited by the researchers for further investigations. These data add to a growing body of evidence on the biological activities of extracts from these plants. Compounds reported in our GC-MS profiling may be applied in treating Tuberculosis, Non-small-cell lung cancer and to design rationalized drugs. |